FocusBar
Stocks
Gurus
Last Quotes
My portfolios
Ben Graham Net Asset Bargain Companies
Undervalued Predictable Companies
Buffett Munger Screener Companies
Low P/B Companies
Low P/S Companies
52-Week Lows
52-Week Highs
Predictable Companies
All Gurus
My Gurus
Feedback
Home
Home
Homepage
Membership
Knowledge Center
Message from Founder
About GuruFocus
Jobs
FAQ
Forum
RSS Feed
Contact
Premium Membership
Premium Membership ($299/Year)
Monthly Newsletters:
Ben Graham Net-Net
Buffett-Munger Bargains
Micro-Cap Magic Formula
Screeners
Try Our All-In-One Screener
Value Screens
All-In-One Screener
Ben Graham Net-Net
Undervalued Predictable
Buffett-Munger Screener
Greenblatt Magic Formula
Low P/S Companies
Low P/B Companies
DCF Screener
52-Week Lows
52-Week Highs
3-Year Lows
3-Year Highs
5-Year Lows
5-Year Highs
Predictables Companies
S&P 500 Grid
Dividend Stocks
DCF Calculator
Model Portfolios
Performances
All Model Portfolios
Buffett-Munger (+103.08%)
Undervalued Predictable (+113.34%)
Low P/S (+59.52%)
Low P/B (+51.81%)
Broadest Owned (+36.78%)
Most Weighted (+36.83%)
Gurus
Guru Stocks
Latest Guru Picks
Real Time Picks
List of Gurus (Personalize)
Gurus Portfolios
Scoreboard
Sector Picks
International Picks
Download Portfolio
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Industry Trends
Geographic Trend
Guru Screener (Old)
ETFs
Options
Preferred Stocks
European Shorting
Insiders
All Insiders
CEO Buys/Sales
CFO Buys/Sales
Insider Cluster
Guru+Insider Double Buys
Triple Buys/Sales
Insider Trends
Download
Canadian Insider
Market
Market Valuation
Market-Cap/GDP Valuation
Global Market Valuation
Shiller P/E
Market in Foreign Currencies
By Country
USA
Australia
Brazil
Canada
China
France
Germany
India
Japan
UK
More...
Articles
Articles
All Articles
GuruFocus Research
Editor's Picks
Guru News
Value Ideas
Dividend Stocks
Interviews with Gurus
Top Ranked
Value Idea Contest
Videos
Submit Articles
Writers Wanted
Value Contest Winners
Contest Announcement (Win $1000)
Submit Articles Online
Portfolios
My Portfolios
Create New Portfolio
Explore Portfolios
LOG IN
Log In
Free Register
7-Day Free Trial
SUBSCRIBE
7-Day Free Trial
Subscribe ($299/Year)
Premium vs. Free
Contact Us
My Portfolios
Browse Gurus
Total Records:
38
The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP Pharmaceuticals Inc. in Connection With the Sale of the Company to Allergan Inc. --
-
Feb. 01, 2013
MAP Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference
-
Jan. 02, 2013
MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA Resubmission for LEVADEX®
-
Nov. 21, 2012
MAP Pharmaceuticals Reports Third Quarter of 2012 Financial Results
-
Nov. 01, 2012
MAP Pharmaceuticals to Present Data on LEVADEX® at the 54th Annual Scientific Meeting of the American Headache Society
-
Jun. 21, 2012
Appointment of Scott R. Ward as Creganna-Tactx Medical Chairman
-
May. 24, 2012
MAP Pharmaceuticals, Inc. (MAPP) President and CEO Timothy S Nelson sells 80,000 Shares
-
Jan. 25, 2013
MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results
-
May. 04, 2012
Robbins Umeda LLP Announces an Investigation of MAP Pharmaceuticals, Inc.
-
May. 02, 2012
MAP Pharmaceuticals to Present at Upcoming Investor Conferences
-
May. 01, 2012
MAP PHARMACEUTICALS, INC. Reports Operating Results (10-Q)
-
Nov. 06, 2012
MAP Pharmaceuticals Receives Complete Response Letter from FDA for LEVADEX® (dihydroergotamine) NDA
-
Mar. 26, 2012
MAP PHARMACEUTICALS, INC. Reports Operating Results (10-Q)
-
Jul. 27, 2012
MAP PHARMACEUTICALS, INC. Reports Operating Results (10-Q)
-
May. 08, 2012
MAP PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A)
-
Mar. 31, 2012
MAP PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A)
-
Mar. 31, 2012
MAP PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A)
-
Mar. 31, 2012
MAP PHARMACEUTICALS, INC. Reports Operating Results (10-K)
-
Mar. 31, 2012
MAP Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
-
Jan. 04, 2012
MAP Pharmaceuticals to Present at Upcoming Investor Conferences
-
Nov. 03, 2011
MAP PHARMACEUTICALS, INC. Reports Operating Results (10-Q)
-
Nov. 08, 2011
Currently 4.50/5
Rating:
4.5
/5 (2 votes)
Weekly CFO Sells Highlight: AXAS, MDW, MAPP, CATM, OVRL
-
Sep. 24, 2011
MAP PHARMACEUTICALS, INC. (MAPP) CFO Christopher Y Chai sells 32,000 Shares
-
Sep. 22, 2011
MAP Pharmaceuticals to Present at Upcoming Investor Conferences
-
Sep. 06, 2011
MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA for LEVADEX®
-
Aug. 02, 2011
MAP PHARMACEUTICALS, INC. Reports Operating Results (10-K)
-
Mar. 04, 2011
MAP PHARMACEUTICALS, INC. (MAPP) CFO Christopher Y Chai sells 16,000 Shares
-
Sep. 22, 2010
MAP PHARMACEUTICALS, INC. (MAPP) CFO Christopher Y Chai sells 16,000 Shares
-
Jul. 22, 2010
MAP PHARMACEUTICALS, INC. (MAPP) President and CEO Timothy S Nelson sells 15,000 Shares
-
Jul. 02, 2010
MAP PHARMACEUTICALS, INC. (MAPP) President and CEO Timothy S Nelson sells 30,000 Shares
-
Jun. 03, 2010
MAP PHARMACEUTICALS, INC. (MAPP) CFO Christopher Y Chai sells 16,000 Shares
-
May. 21, 2010
MAP PHARMACEUTICALS, INC. (MAPP) President and CEO Timothy S Nelson sells 30,000 Shares
-
May. 14, 2010
MAP PHARMACEUTICALS, INC. (MAPP) CFO Christopher Y Chai sells 16,000 Shares
-
Mar. 25, 2010
MAP PHARMACEUTICALS, INC. (MAPP) President and CEO Timothy S Nelson sells 30,000 Shares
-
Mar. 03, 2010
MAP PHARMACEUTICALS, INC. (MAPP) President and CEO Timothy S Nelson sells 20,000 Shares
-
Jan. 13, 2010
MAP PHARMACEUTICALS, INC. (MAPP) CFO Christopher Y Chai sells 10,000 Shares
-
Nov. 04, 2009
MAP PHARMACEUTICALS, INC. (MAPP) CFO Christopher Y Chai sells 10,000 Shares
-
Oct. 05, 2009
Currently 4.00/5
Rating:
4.0
/5 (1 vote)
MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results
-
Aug. 03, 2009
Total Records:
38
GuruFocus Affiliate Program: Earn up to $400 per referral. (
Learn More
)
Get WordPress Plugins
for easy affiliate links on Stock Tickers and Guru Names
FEEDBACK